Denis Drygin

Insider Reports History

Location
San Diego, CA
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Denis Drygin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Chief Scientific Officer Common Stock 100,000 $119,060 $1.19 01 Mar 2022 Direct

Insider Reports Filed by Denis Drygin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 01 Mar 2022 1 +$17,638 4 Chief Scientific Officer 01 Mar 2022, 16:58
RGLS Regulus Therapeutics Inc. 04 Feb 2022 1 +$5,362 4 Chief Scientific Officer 07 Feb 2022, 16:09
RGLS Regulus Therapeutics Inc. 12 Jan 2022 1 $0 4 Chief Scientific Officer 26 Jan 2022, 15:14